Oligosaccharide adjuvant-deferred antigen endocytosis promotes cross-presentation.
- DOI
- 10.1016/j.bioactmat.2026.08.052
- Published
- 2027 Feb
- Container
- Bioactive materials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioactmat.2026.08.052,
title = {Oligosaccharide adjuvant-deferred antigen endocytosis promotes cross-presentation.},
author = {Li Y and Xie D and Niu Y and Chen J and Dong L and Sun B and Zhang R and Xu F and Wang C},
year = {2027},
journal = {Bioactive materials},
doi = {10.1016/j.bioactmat.2026.08.052},
url = {https://doi.org/10.1016/j.bioactmat.2026.08.052}
}RIS
TY - JOUR TI - Oligosaccharide adjuvant-deferred antigen endocytosis promotes cross-presentation. AU - Li Y AU - Xie D AU - Niu Y AU - Chen J AU - Dong L AU - Sun B AU - Zhang R AU - Xu F AU - Wang C PY - 2027 JO - Bioactive materials DO - 10.1016/j.bioactmat.2026.08.052 UR - https://doi.org/10.1016/j.bioactmat.2026.08.052 ER -
APA
Y, L., D, X., Y, N., J, C., L, D., B, S., R, Z., F, X., & C, W. (2027). Oligosaccharide adjuvant-deferred antigen endocytosis promotes cross-presentation.. Bioactive materials. https://doi.org/10.1016/j.bioactmat.2026.08.052
Source records
- pubmed · retrieved 2026-09-25T05:51:25.271Z